S&P 500   4,005.45 (+0.64%)
DOW   31,752.19 (+0.54%)
QQQ   300.79 (+0.61%)
AAPL   155.72 (-0.15%)
MSFT   259.56 (+0.57%)
META   161.51 (+0.70%)
GOOGL   109.33 (-0.11%)
AMZN   129.81 (+0.25%)
TSLA   287.70 (+1.41%)
NVDA   138.73 (+1.16%)
NIO   17.58 (+0.57%)
BABA   90.09 (-0.56%)
AMD   82.47 (+3.59%)
T   16.86 (-0.06%)
MU   55.12 (+0.22%)
CGC   3.42 (+0.29%)
F   15.23 (-1.30%)
GE   73.69 (+0.15%)
DIS   112.78 (+0.08%)
AMC   8.57 (+2.15%)
PYPL   96.02 (+1.11%)
PFE   46.71 (+1.26%)
NFLX   227.65 (-0.57%)
S&P 500   4,005.45 (+0.64%)
DOW   31,752.19 (+0.54%)
QQQ   300.79 (+0.61%)
AAPL   155.72 (-0.15%)
MSFT   259.56 (+0.57%)
META   161.51 (+0.70%)
GOOGL   109.33 (-0.11%)
AMZN   129.81 (+0.25%)
TSLA   287.70 (+1.41%)
NVDA   138.73 (+1.16%)
NIO   17.58 (+0.57%)
BABA   90.09 (-0.56%)
AMD   82.47 (+3.59%)
T   16.86 (-0.06%)
MU   55.12 (+0.22%)
CGC   3.42 (+0.29%)
F   15.23 (-1.30%)
GE   73.69 (+0.15%)
DIS   112.78 (+0.08%)
AMC   8.57 (+2.15%)
PYPL   96.02 (+1.11%)
PFE   46.71 (+1.26%)
NFLX   227.65 (-0.57%)
S&P 500   4,005.45 (+0.64%)
DOW   31,752.19 (+0.54%)
QQQ   300.79 (+0.61%)
AAPL   155.72 (-0.15%)
MSFT   259.56 (+0.57%)
META   161.51 (+0.70%)
GOOGL   109.33 (-0.11%)
AMZN   129.81 (+0.25%)
TSLA   287.70 (+1.41%)
NVDA   138.73 (+1.16%)
NIO   17.58 (+0.57%)
BABA   90.09 (-0.56%)
AMD   82.47 (+3.59%)
T   16.86 (-0.06%)
MU   55.12 (+0.22%)
CGC   3.42 (+0.29%)
F   15.23 (-1.30%)
GE   73.69 (+0.15%)
DIS   112.78 (+0.08%)
AMC   8.57 (+2.15%)
PYPL   96.02 (+1.11%)
PFE   46.71 (+1.26%)
NFLX   227.65 (-0.57%)
S&P 500   4,005.45 (+0.64%)
DOW   31,752.19 (+0.54%)
QQQ   300.79 (+0.61%)
AAPL   155.72 (-0.15%)
MSFT   259.56 (+0.57%)
META   161.51 (+0.70%)
GOOGL   109.33 (-0.11%)
AMZN   129.81 (+0.25%)
TSLA   287.70 (+1.41%)
NVDA   138.73 (+1.16%)
NIO   17.58 (+0.57%)
BABA   90.09 (-0.56%)
AMD   82.47 (+3.59%)
T   16.86 (-0.06%)
MU   55.12 (+0.22%)
CGC   3.42 (+0.29%)
F   15.23 (-1.30%)
GE   73.69 (+0.15%)
DIS   112.78 (+0.08%)
AMC   8.57 (+2.15%)
PYPL   96.02 (+1.11%)
PFE   46.71 (+1.26%)
NFLX   227.65 (-0.57%)
OTC:BLMMF

Blackmores - BLMMF Price Target & Analyst Ratings

Add
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
100 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Blackmores Consensus Rating and Price Target (2022)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 2 Analyst Ratings

Consensus Analyst Price Target

$90.00
High Prediction$90.00
Average Prediction$90.00
Low Prediction$90.00
TypeCurrent
9/8/21 to 9/8/22		1 Month Ago
8/9/21 to 8/9/22		3 Months Ago
6/10/21 to 6/10/22		1 Year Ago
9/8/20 to 9/8/21
Consensus Rating
Hold
Hold
Hold
N/A
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
 N/A
Buy
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
 N/A
Hold
2 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
 N/A
Sell
0 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
 N/A
Consensus Price Target$90.00$90.00$90.00N/A
Predicted UpsideN/AN/AN/AN/A
Get Blackmores Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for BLMMF and its competitors with MarketBeat's FREE daily newsletter.


BLMMF Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

BLMMF Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Blackmores Stock vs. The Competition

TypeBlackmoresMedical CompaniesS&P 500
Consensus Rating Score
2.00
2.70
2.49
Consensus RatingHoldBuyHold
Predicted Upside1,250.40% Upside21.72% Upside
News Sentiment RatingNeutral News
Neutral News
Neutral News
MarketBeat
Community Rating		 Outperform Votes
No Votes
Underperform Votes
3
100.00%
Avg. Outperform Votes
166
66.67%
Avg. Underperform Votes
83
33.33%
Avg. Outperform Votes
851
68.46%
Avg. Underperform Votes
392
31.54%

Historical Target Prices and Ratings

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
9/8/2022The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageNeutral
2/25/2022Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Larry Gandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating		DowngradeHold$90.00+900,000,000.00%
(Data available from 9/8/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)












BLMMF Price Target - Frequently Asked Questions

What is Blackmores's consensus rating and price target?

According to the issued ratings of 2 analysts in the last year, the consensus rating for Blackmores stock is Hold based on the current 2 hold ratings for BLMMF. The average twelve-month price prediction for Blackmores is $90.00 with a high price target of $90.00 and a low price target of $90.00. Learn more on BLMMF's analyst rating history.

Do Wall Street analysts like Blackmores more than its competitors?

Analysts like Blackmores less than other Medical companies. The consensus rating for Blackmores is Hold while the average consensus rating for medical companies is Buy. Learn more on how BLMMF compares to other companies.

Do MarketBeat users like Blackmores more than its competitors?

MarketBeat users like Blackmores less than other Medical companies. 0.00% of MarketBeat users gave Blackmores an outperform vote while medical companies recieve an average of 66.67% outperform votes by MarketBeat users.

What analysts cover Blackmores?

Blackmores has been rated by The Goldman Sachs Group in the past 90 days.


Stock Ratings Reports and Tools

Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
Ratings for Popular Stocks:
This page (OTC:BLMMF) was last updated on 9/8/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice YouTube

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.